FDA Approves Moderna’s mFlusiva, Marking a Landmark Entry for mRNA Technology into Seasonal Flu Vaccination
admin The U.S. Food and Drug Administration (FDA) has granted approval for mFlusiva, previously known as...
admin
Cancer interrupted his childhood. Today, he’s living his dream on the court.
The journey from a pediatric oncology ward to the hardwood of a Division I basketball...
Braveheart Bio Spearheads Biotech IPO Surge, As Five Firms Secure Over $1 Billion in Public Offerings This Week
Braveheart Bio, a rapidly emerging biotechnology company focused on cardiovascular therapies, has successfully completed its...
Novo Nordisk Faces Setbacks as Eli Lilly’s Injectable Franchise Continues to Outperform in Fierce GLP-1 Market
The intense rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly in the burgeoning market...
Randy Moss Joins the Fight Against Pediatric Cancer as the Extraordinary Legacy of Katie Hageboeck Continues to Transform Childhood Oncology Research
The intersection of professional sports and philanthropy often highlights high-profile donations and star-studded galas, but...
CureSearch Awards Young Investigator Grant to Dr. Kathryn Taylor for Innovative Pediatric Brain Cancer Research
The landscape of pediatric oncology is undergoing a transformative shift as researchers move beyond traditional...
Attovia Therapeutics Secures $289 Million in Upsized IPO, Signifying Robust Biotech Market Recovery
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
Honoring Nathan Gray: How a Family’s Grief Transformed Into a Million Dollar Crusade Against Relapsed Wilms Tumor
The transition into the fourth grade is a traditional milestone for American elementary students, usually...
Breakthrough Research Grant Targets Metastatic Ewing Sarcoma Through Innovative CAR T-Cell Therapy and Interleukin-18 Integration
The landscape of pediatric oncology is facing a potential paradigm shift as Dr. John Lee...
Cancer Research Institute Announces 2026 Lloyd J. Old STARs: Five Visionary Scientists Poised to Transform Immunotherapy with $1.25 Million Each
The Cancer Research Institute (CRI) has proudly unveiled its 2026 class of Lloyd J. Old...
